Sequana Medical NV (id:404 SEQUA)
2.76 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:26:12 PM)
Exchange open, closes in 3 minutes
21.05 EUR (21.05%)
283.33 EUR (283.33%)
206.67 EUR (206.67%)
100.00 EUR (100.00%)
-32.02 EUR (-32.02%)
-54.90 EUR (-54.90%)
-67.53 EUR (-67.53%)
About Sequana Medical NV
Market Capitalization 30.57M
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
| Headquarters (address) |
Kortrijksesteenweg 1112 Gent 9051 Belgium |
| Phone | 32 9 298 28 28 |
| Website | https://www.sequanamedical.com |
| Employees | 62 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | SEQUA |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 3.00 - 4.85 |
| Market Capitalization | 30.57M |
| P/E trailing | 3.00 |
| P/E forward | 3.00 |
| Price/Sale | 70.52 |
| Beta | 3.00 |
| EPS | 3.00 |
| EPS Belgium (ID:14, base:79) | 4.60 |